Network origin in Christopher F. Mojcik first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
| Subsidiary | Pharmaceuticals: Major | 26 | |
Bayer Corp.
 Bayer Corp. Pharmaceuticals: MajorHealth Technology Bayer Corp. manufactures and markets pharmaceutical, healthcare, nutrition and materials products. The firm offers consumer care, diagnostics, diabetes and animal health products. It also provides material science products, which include coating, adhesive and sealant raw materials polycarbonates polyurethanes and thermoplastic polyurethane elastomers. The company was founded in 1973 and is based in Whippany, NJ.
10
| Subsidiary | Pharmaceuticals: Major | 10 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Christopher F. Mojcik via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
| ALLOVIR, INC. | Biotechnology | President Chairman Corporate Officer/Principal Director/Board Member | |
| BIOGEN INC. | Pharmaceuticals: Major | Chief Executive Officer Sales & Marketing Corporate Officer/Principal | |
Purdue Pharma LP
 Purdue Pharma LP Pharmaceuticals: MajorHealth Technology Purdue Pharma LP engages in the development and provision of prescription medicines. It offers a portfolio of medical products in categories, including prescription opioids, sleep, laxatives, antiseptics, and dietary supplement. The company was founded by Raymond R. Sackler in 1991 and is headquartered in Stamford, CT. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Corporate Officer/Principal Corporate Officer/Principal | |
| BAYER AG | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Comptroller/Controller/Auditor | |
| AMGEN INC. | Pharmaceuticals: Major | Sales & Marketing Corporate Officer/Principal Sales & Marketing | |
| INTERMUNE INC | Biotechnology | Chief Tech/Sci/R&D Officer Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
LifeEDIT Therapeutics, Inc.
 LifeEDIT Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Part of ElevateBio LLC, LifeEDIT Therapeutics, Inc. is a next-generation genome editing company that has built a highly innovative platform with one of the world's largest and most diverse collections of novel RNA-guided nucleases (RGNs) and base editors. The company offers gene editing tools with higher fidelity, novel functionality, reduced immune response risk, and easier delivery. LifeEDIT has a large and diverse library of RGNs, including type II and type V systems that encompass knock-out and knock-in capabilities, transcriptional regulation, and base editing when coupled with one of their proprietary deaminases. The company's nuclease collection has a broad range of protospacer adjacent motifs (PAMs), offering unprecedented access to genomes. LifeEDIT is headquartered in Morrisville, NC. The CEO of the company is Mitchell H. Finer. LifeEDIT Therapeutics was acquired by ElevateBio LLC from AgBiome Delta LLC on October 27, 2021. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
ElevateBio LLC
 ElevateBio LLC BiotechnologyHealth Technology ElevateBio LLC is a biotechnology holding company, which creates and operates a broad portfolio of cell and gene therapy companies. It builds single and multi-product companies by providing scientific founders with bench-to-bedside capabilities including scientists, manufacturing facilities, drug developers, and commercial expertise. The company was founded by David L. Hallal, Vikas Sinha, and Mitchell H. Finer and is headquartered in Cambridge, MA. | Biotechnology | Founder Chief Executive Officer | |
| PFIZER, INC. | Pharmaceuticals: Major | Sales & Marketing Corporate Officer/Principal | |
| NOVO NORDISK A/S | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
Cornell University
 Cornell University Other Consumer ServicesConsumer Services Cornell University is an educational institution that offers undergraduate and post graduate programs. It was founded in 1865 and is based in Ithaca, NY. | College/University | Director/Board Member Doctorate Degree | |
| Bayer Pharmaceuticals Corp. | Director of Finance/CFO Corporate Officer/Principal | ||
Pharmaceutical Research & Manufacturers of America
 Pharmaceutical Research & Manufacturers of America Pharmaceuticals: MajorHealth Technology Pharmaceutical Research & Manufacturers of America provides pharmaceutical research and biotechnology services. It represents the country’s biopharmaceutical research companies, which are devoted to discovering and developing medicines that enable patients to live longer, healthier, and more productive lives. The company was founded in 1958 and is headquartered Washington, DC. | Pharmaceuticals: Major | Chairman Director/Board Member | |
| McGill University | College/University | Undergraduate Degree Doctorate Degree | |
| The University of California, San Francisco | College/University | Corporate Officer/Principal Corporate Officer/Principal | |
| INSULET CORPORATION | Medical Specialties | Director of Finance/CFO Director of Finance/CFO | |
EMD Serono, Inc.
 EMD Serono, Inc. Pharmaceuticals: MajorHealth Technology EMD Serono, Inc. operates as a biopharmaceutical firm. The firm develops recombinant prescription medicines. Its therapies include neurology and immunology, metabolic endocrinology, fertility, and oncology. The company was founded in 1971 and is headquartered in Rockland, MA. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| ALNYLAM PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Chief Tech/Sci/R&D Officer | |
New Haven Pharmaceuticals, Inc.
 New Haven Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology New Haven Pharmaceuticals, Inc. develops new prescription drug products. It developes proprietary prescription pharmaceuticals that utilize currently marketed drugs or generally recognized as safe (GRAS) active pharmaceutical ingredients (APIs) for use in therapeutic applications. The company was founded by Harry H. Penner Jr. in 2008 and is headquartered in Branford, CT. | Pharmaceuticals: Major | General Counsel Chief Administrative Officer | |
| Toronto East General Hospital Foundation | Director/Board Member | ||
| HARROW, INC. | Pharmaceuticals: Major | Director/Board Member | |
Medical Marketing Economics LLC
 Medical Marketing Economics LLC Miscellaneous Commercial ServicesCommercial Services Part of Indegene Ltd., Medical Marketing Economics LLC engages in value-based strategies and market research for health care goods and services. The company is based in Oxford, MS. Medical Marketing Economics was acquired by Indegene Ltd. on August 30, 2021 for $10 million. The company was founded in 2001. The CEO is Jack M. Mycka. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
| Westmont College | College/University | Undergraduate Degree | |
GlaxoSmithKline, Inc.
 GlaxoSmithKline, Inc. Pharmaceuticals: MajorHealth Technology GlaxoSmithKline, Inc. manufactures and markets pharmaceutical products. The company develops medicines to prevent infections that cause serious medical problems such as respiratory illnesses, diabetes, viral control, infections, and central nervous system disorders. The company is headquartered in Mississauga, Canada. | Pharmaceuticals: Major | Sales & Marketing | |
American Society of Hematology
 American Society of Hematology Miscellaneous Commercial ServicesCommercial Services American Society of Hematology provides the most current practice tools, clinical support and educational products needed in hematology. The firm offers educational products and services for clinicians and scientists. The company is headquartered in Washington, DC. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
| University of Cape Town | College/University | Doctorate Degree | |
Angiocrine Bioscience, Inc.
 Angiocrine Bioscience, Inc. Miscellaneous Commercial ServicesCommercial Services Angiocrine Bioscience, Inc. is a clinical-stage biotechnology company based on its novel and proprietary e-cel® platform. The company is based in San Diego, CA. The company is developing multiple e-cel therapies designed to repair damaged tissue from age-related degenerative disease of the musculoskeletal system, immune diseases that attack vessels and tissues, and ischemic diseases involving soft tissue, central nervous system, and the heart. The CEO of the company is Paul W. Finnegan. | Miscellaneous Commercial Services | Chief Executive Officer | |
| University of the Witwatersrand | College/University | Undergraduate Degree | |
| CLEMENTIA PHARMACEUTICALS INC | Pharmaceuticals: Major | Corporate Officer/Principal | |
| University of Pittsburgh | College/University | Undergraduate Degree | |
| Indiana University | College/University | Doctorate Degree | |
Moat Biotechnology Corp.
 Moat Biotechnology Corp. Pharmaceuticals: MajorHealth Technology Moat Biotechnology Corp. is a biopharmaceutical company that focuses on developing vaccines. The company is based in Oklahoma City, OK. | Pharmaceuticals: Major | Director/Board Member | |
| Murray State University (Kentucky) | College/University | Undergraduate Degree | |
| Emory University | College/University | Doctorate Degree | |
Genzyme Corp.
 Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Medical Specialties | Corporate Officer/Principal | |
| CORVUS PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Founder | |
MedImmune LLC
 MedImmune LLC BiotechnologyHealth Technology MedImmune LLC develops medicines for the prevention and treatment of infectious diseases such as cancer and immune system disorders. It offers solutions in the areas of monoclonal antibodies and vaccines for infection, oncology, respiratory disease and inflammation, cardiovascular diseases, and neuroscience. The company was founded by Wayne T. Hockmeyer in 1988 and is headquartered in Gaithersburg, MD. | Biotechnology | Corporate Officer/Principal | |
| PHARMACYCLICS, INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Axys Pharmaceuticals, Inc.
 Axys Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Axys Pharmaceuticals, Inc. engages in the development of integrated drugs. The company is headquartered in South San Francisco, CA. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Tetherex Pharmaceuticals Corp.
 Tetherex Pharmaceuticals Corp. BiotechnologyHealth Technology Tetherex Pharmaceuticals Corp. operates as a biopharmaceutical company. It focuses on development of therapeutics for the treatment of thrombosis, inflammation and tumor metastasis across a broad range of severe diseases. The company was founded by Rodger P. McEver and Richard D. Cummings and is headquartered in Oklahoma City, OK. | Biotechnology | President | |
| SEER, INC. | Biotechnology | Director/Board Member |
Statistics
International
| United States | 42 |
| Canada | 5 |
| South Africa | 3 |
| Germany | 2 |
| Denmark | 2 |
Sectoral
| Health Technology | 31 |
| Consumer Services | 11 |
| Commercial Services | 6 |
| Finance | 2 |
Operational
| Director/Board Member | 103 |
| Corporate Officer/Principal | 94 |
| Independent Dir/Board Member | 34 |
| Undergraduate Degree | 32 |
| President | 26 |
Most connected contacts
| Insiders | |
|---|---|
| George Scangos | 33 |
| Rockford Norby | 28 |
| Darren Cline | 15 |
| David Hallal | 15 |
| Carsten Boess | 15 |
| Lars Robert Boesgaard | 14 |
| Jeremy Springhorn | 14 |
| Patrice Coissac | 13 |
| Vikas Sinha | 13 |
| Thomas Dubin | 13 |
| James Pennington | 12 |
| Albert P. L. Stroucken | 11 |
| Larry L. Mathis | 11 |
| Nancy C. Motola | 10 |
| Ruedi E. Waeger | 10 |
- Stock Market
- Insiders
- Christopher F. Mojcik
- Company connections
